OSE Immunotherapeutics SA
PAR:OSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
V
|
Voya Financial Inc
F:V0Y
|
US |
|
T
|
Teads BV
NASDAQ:TEAD
|
NL |
|
C
|
China Resources Beer Holdings Co Ltd
XHAM:CHK
|
HK |
|
R
|
RMK Energy PT Tbk
IDX:RMKE
|
ID |
|
C
|
Cognizant Technology Solutions Corp
SWB:COZ
|
US |
|
C
|
Commerzbank AG
XBER:CBK
|
DE |
|
Ina Invest Holding AG
SIX:INA
|
CH |
|
A
|
ABS-CBN Corporation
XPHS:ABS
|
PH |
|
Worldline SA
PAR:WLN
|
FR |
|
S
|
Seabridge Gold Inc
NYSE:SA
|
CA |
|
AxoGen Inc
NASDAQ:AXGN
|
US |
|
T Rowe Price Group Inc
NASDAQ:TROW
|
US |
|
Memex Inc
XTSX:OEE
|
CA |
|
E
|
EMC PCL
SET:EMC
|
TH |
|
N
|
Nupur Recyclers Ltd
NSE:NRL
|
IN |
|
Marksans Pharma Ltd
NSE:MARKSANS
|
IN |
|
U
|
Uniqa Insurance Group AG
VSE:UQA
|
AT |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
Paladin Energy Ltd
ASX:PDN
|
AU |
|
Jowell Global Ltd
NASDAQ:JWEL
|
CN |
|
X Fab Silicon Foundries EV
PAR:XFAB
|
BE |
Bankruptcy Probability
OSE Immunotherapeutics SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OSE Immunotherapeutics SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
OSE Immunotherapeutics SA
PAR:OSE
|
82.9m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
383.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OSE Immunotherapeutics SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OSE Immunotherapeutics SA has total debt of 32.5m EUR. This includes both short-term (0 EUR) and long-term (32.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.
